Semaglutide is designed to reduce appetite and food cravings by mimicking a hormone called GLP-1, which sends signals to the brain that you are full
If you are a PBM, Cost Plus Drugs is an existential threat in the medium term if the employer market embraces direct-to-employer models at scale
The vascular protective effect of GLP-1 receptor agonists is partly attributed to improved metabolic impact and improved glycemic control
In fact, many patients report that the initial side effects diminish significantly after the first few weeks of therapy, as their bodies adapt to the medication
The right choice comes down to your routine, preferences, and medical suitability
It depends, but many people start with baseline checks and then periodic follow-ups every few months, with more frequent checks when diabetes medications or symptoms require closer monitoring